📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Ncardia

1.1 - Company Overview

Ncardia Logo

Ncardia

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of iPSC-based drug discovery platforms and predictive human cellular assay systems to expedite drug discovery from hit identification to lead optimization. Offers Ncyte Smooth Muscle Cells, Astrocytes, Endothelial Cells, Neural Mix, and vCardiomyocytes for in vitro modeling, safety and efficacy testing, cardiovascular and neural screening, pharmacology, toxicity, electrophysiology, and disease modeling.

Products and services

  • IPSC-based Drug Discovery Platform: Custom-engineered integrated iPSC platform that architects predictive human cellular assay systems to mimic drug interactions, supporting safety and efficacy testing from hit identification through lead optimization
  • Ncyte® vCardiomyocytes: Research-grade human iPSC-derived ventricular cardiomyocytes constructed for pharmacology and toxicity assays, exhibiting characteristics of human ventricular cells to enhance cardiovascular drug screening accuracy
  • Ncyte® Astrocytes: In vitro human iPSC-derived astrocytes engineered for long-term electrophysiological studies, disease modeling of neurodegenerative diseases, and in vitro testing to evaluate neural responses

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Ncardia

Sirigen Logo

Sirigen

HQ: United Kingdom Website
  • Description: Provider of light-harvesting polymer materials and High Sensitivity Fluorescence (HSF) technology for diagnostic and life science applications. Offers HSF to enhance signals, lower detection limits and improve multiplexing; Brilliant Violet dyes for violet lasers and flow cytometry; and solutions for immunoassays/ELISA, biomarkers/proteomics, and lateral flow/point-of-care with simplified sample processing and instrumentation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sirigen company profile →
Purolite Logo

Purolite

HQ: United Kingdom Website
  • Description: Provider of pharmaceutical resin products used as APIs or excipients; marketed APIs cholestyramine and sodium polystyrene sulfonate; excipients for taste-masking, carriers, and disintegrants; PuroMill pharmaceutical-grade milling media for nanoparticles <100 nm to enhance solubility; and polymeric and chromatography resins for biofluid treatment, separation, purification, and medical device diagnostic and treatment applications.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Purolite company profile →
Microchips Biotech Logo

Microchips Biotech

HQ: United States Website
  • Description: Provider of a proprietary microchip-based implant for long-term, precise drug delivery. The subcutaneous device stores and releases exact doses over months and years and is placed under the skin by a trained physician in a simple office procedure using local anesthesia.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Microchips Biotech company profile →
Alsachim Logo

Alsachim

HQ: France Website
  • Description: Provider of contract research and development services to customers around the world, stable isotope-labeled compounds for pharmaceuticals, environmental studies, and clinical diagnostics, and labeled internal and reference standards for LC-MS/MS analysis to ensure accurate quantification.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alsachim company profile →
NorthStar Medical Radioisotopes Logo

NorthStar Medical Radioisotopes

HQ: United States Website
  • Description: Provider of radioisotopes and radiopharmaceutical CDMO/CMO services for the nuclear medicine market, producing Actinium-225 (Ac-225) and Copper-67 (Cu-67) in scalable, commercial quantities via electron beam accelerators, and delivering end-to-end contract development and manufacturing from research to commercialization, with environmentally friendly accelerator-based production of multiple isotopes.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NorthStar Medical Radioisotopes company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Ncardia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Ncardia

2.2 - Growth funds investing in similar companies to Ncardia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Ncardia

4.2 - Public trading comparable groups for Ncardia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Ncardia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Ncardia

What does Ncardia do?

Ncardia is a provider of iPSC-based drug discovery platforms and predictive human cellular assay systems to expedite drug discovery from hit identification to lead optimization. Offers Ncyte Smooth Muscle Cells, Astrocytes, Endothelial Cells, Neural Mix, and vCardiomyocytes for in vitro modeling, safety and efficacy testing, cardiovascular and neural screening, pharmacology, toxicity, electrophysiology, and disease modeling.

Who are Ncardia's competitors?

Ncardia's competitors and similar companies include Sirigen, Purolite, Microchips Biotech, Alsachim, and NorthStar Medical Radioisotopes.

Where is Ncardia headquartered?

Ncardia is headquartered in The Netherlands.

How many employees does Ncardia have?

Ncardia has 1,000 employees 🔒.

When was Ncardia founded?

Ncardia was founded in 2010 🔒.

What sector and industry vertical is Ncardia in?

Ncardia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ncardia

Who are the top strategic acquirers in Ncardia's sector and industry

Top strategic M&A buyers and acquirers in Ncardia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ncardia?

Top strategic M&A buyers groups and sectors for Ncardia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ncardia's sector and industry vertical

Which are the top PE firms investing in Ncardia's sector and industry vertical?

Top PE firms investing in Ncardia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ncardia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ncardia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ncardia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ncardia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ncardia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ncardia?

The key public trading comparables and valuation benchmarks for Ncardia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ncardia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ncardia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ncardia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ncardia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ncardia's' sector and industry vertical?

Access recent funding rounds and capital raises in Ncardia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Ncardia